The EU Joint Clinical Assessment (JCA) is expected to require considerable time and resources from both countries and ...

Sanofi has announced the opening of its new €558m-backed manufacturing facility in Singapore, which the company says ...

GSK’s fully liquid presentation of its meningococcal vaccine Menveo has been approved by the European Commission (EC) to ...

Gastric cancer is the fifth leading cause of cancer-related deaths globally and oesophageal cancer is the sixth ...

AstraZeneca (AZ) has announced positive high-level results from a late-stage study of its AKT inhibitor Truqap (capivasertib) ...

A UK study has shown that a drug currently used to treat severe asthma could be re-purposed for use in emergency settings, ...

GSK’s linerixibat has shown promising results in a late-stage trial of primary biliary cholangitis (PBC) patients with ...

Novartis’ Kisqali (ribociclib) has been approved by the European Commission (EC) to reduce the risk of disease recurrence in ...

Policymakers, payers, providers, patients and pharma are each uniquely able to impact health equity – and together, achieve ...

The challenges facing the UK’s healthcare system and why putting the patient voice at the heart of our work is key ...

COP29 President-Designate around November’s global climate conference. And reviewing the insights from a recent look at how ...

AstraZeneca (AZ) has announced a $3.5bn investment in the US aimed at expanding its research and manufacturing footprint by ...